CytoDyn Inc. (103)
Browse by Contract Category
Contracts
-
Amended and Restated 2012 Equity Incentive Plan
(Filed With SEC on January 9, 2023)
-
Form Stock Option Award Agreement (For Executives)
(Filed With SEC on January 9, 2023)
-
Second Amendment dated December 1, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein
(Filed With SEC on December 7, 2022)
-
Settlement Agreement dated May 19, 2022, between CytoDyn Inc. and Richard G. Pestell, M.D., Ph.D
(Filed With SEC on August 15, 2022)
-
Commercialization and License Agreement between CytoDyn Inc. and Vyera Pharmaceuticals, LLC, dated December 17, 2019
(Filed With SEC on January 9, 2020)
-
Form Stock Option Award Agreement (For Non-Employee Directors)
(Filed With SEC on January 9, 2023)
-
Description of the Registrants Capital Stock
(Filed With SEC on August 15, 2022)
-
Employment Agreement between CytoDyn Inc. and Cyrus Arman, effective July 9, 2022
(Filed With SEC on August 15, 2022)
-
CERTAIN IDENTIFIED INFORMATION MARKED BY [*] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT...
(Filed With SEC on August 15, 2022)
-
CERTAIN IDENTIFIED INFORMATION MARKED BY [*] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT...
(Filed With SEC on August 15, 2022)
-
CERTAIN IDENTIFIED INFORMATION MARKED BY [*] HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT...
(Filed With SEC on August 15, 2022)
-
Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Biomm S.A., dated April 6, 2021
(Filed With SEC on August 15, 2022)
-
Warrant Issued to Richard G. Pestell
(Filed With SEC on August 15, 2022)
-
Amendment dated July 18, 2022, to Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein
(Filed With SEC on July 25, 2022)
-
Separation Agreement and Release of Claims Claims with Nader Z. Pourhassan, Ph.D., effective March 8, 2022
(Filed With SEC on April 11, 2022)
-
Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein
(Filed With SEC on April 11, 2022)
-
Surety Bond Backstop Agreement dated February 14, 2022, among the Company and certain parties named therein (the Company agrees to furnish a copy of Schedule 3, which has been...
(Filed With SEC on February 17, 2022)
-
Form of Make-Whole Warrant
(Filed With SEC on February 17, 2022)
-
Form of Initial Warrant
(Filed With SEC on February 17, 2022)
-
Form of Subscription Agreement
(Filed With SEC on November 23, 2021)
-
Employment Agreement by and between CytoDyn Inc. and Antonio Migliarese, effective May 18, 2021
(Filed With SEC on October 12, 2021)
-
Form of Warrant Exercise Inducement Agreement
(Filed With SEC on September 7, 2021)
-
Form of Subscription Agreement
(Filed With SEC on September 7, 2021)
-
Form of Warrant
(Filed With SEC on September 7, 2021)
-
Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Chiral Pharma Corporation
(Filed With SEC on July 30, 2021)
-
Description of the Registrants Capital Stock
(Filed With SEC on July 30, 2021)
-
Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Biomm S.A., dated April 6, 2021
(Filed With SEC on July 30, 2021)
-
Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Chiral Pharma Corporation, as amended by Amendment No. 1, dated April 19, 2021
(Filed With SEC on July 30, 2021)
-
Exclusive Supply and Distribution Agreement between CytoDyn Inc. and Macleods Pharmaceuticals Ltd., dated May 11, 2021
(Filed With SEC on July 30, 2021)
-
Separation Agreement and Release of Claims between CytoDyn Inc. and Mahboob U. Rahman, M.D., Ph.D., dated June 1, 2021
(Filed With SEC on July 30, 2021)
-
Security Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021
(Filed With SEC on April 29, 2021)
-
Securities Purchase Agreement between CytoDyn Inc. and Uptown Capital, LLC dated April 23, 2021
(Filed With SEC on April 29, 2021)
-
Secured Convertible Promissory Note dated April 23, 2021
(Filed With SEC on April 29, 2021)
-
Employment Agreement by and between CytoDyn Inc. and Christopher P. Recknor, M.D., dated March 11, 2021
(Filed With SEC on April 14, 2021)
-
Secured Convertible Promissory Note dated April 2, 2021
(Filed With SEC on April 8, 2021)
-
Security Agreement between CytoDyn Inc. and Streeterville Capital LLC dated April 2, 2021
(Filed With SEC on April 8, 2021)
-
Securities Purchase Agreement between CytoDyn Inc. and Streeterville Capital LLC dated April 2, 2021
(Filed With SEC on April 8, 2021)
-
Form of Warrant Exercise Inducement Agreement
(Filed With SEC on January 29, 2021)
-
Employment Agreement by and between CytoDyn Inc. and Mahboob Rahman M.D., Ph.D., dated October 16, 2020
(Filed With SEC on January 8, 2021)
-
Secured Convertible Promissory Note dated November 10, 2020
(Filed With SEC on November 16, 2020)
-
Securities Purchase Agreement between CytoDyn Inc. and Streeterville Capital, LLC dated November 10, 2020
(Filed With SEC on November 16, 2020)
-
Security Agreement between CytoDyn Inc. and Streeterville Capital, LLC dated November 10, 2020
(Filed With SEC on November 16, 2020)
-
Distribution and Supply Agreement between CytoDyn Inc. and American Regent, Inc. dated July 2, 2020
(Filed With SEC on August 18, 2020)
-
General Release and Separation Agreement between CytoDyn Inc. and Craig S. Eastwood, dated April 24, 2020
(Filed With SEC on August 14, 2020)
-
CytoDyn Inc. Amended and Restated 2012 Equity Incentive Plan (the 2012 Plan)
(Filed With SEC on August 14, 2020)
-
Form of Stock Option Award Agreement for Executive Employees under the 2012 Plan
(Filed With SEC on August 14, 2020)
-
Amended and Restated Employment Agreement by and between CytoDyn Inc. and Nitya G. Ray, Ph.D., dated June 15, 2020
(Filed With SEC on August 14, 2020)
-
Description of the Registrants Capital Stock
(Filed With SEC on August 14, 2020)
-
Employment Agreement by and between CytoDyn Inc. and Arian Colachis, dated March 16, 2020
(Filed With SEC on August 14, 2020)
-
Employment Agreement by and between CytoDyn Inc. and Scott A. Kelly, M.D., dated April 10, 2020
(Filed With SEC on August 14, 2020)
-
Distribution and Supply Agreement between CytoDyn Inc. and American Regent, Inc
(Filed With SEC on August 14, 2020)
-
Security Agreement between CytoDyn Inc. and Iliad Research and Trading, L.P. dated July 29, 2020
(Filed With SEC on July 31, 2020)
-
Securities Purchase Agreement between CytoDyn Inc. and Iliad Research and Trading, L.P. dated July 29, 2020
(Filed With SEC on July 31, 2020)
-
Secured Convertible Promissory Note dated July 29, 2020
(Filed With SEC on July 31, 2020)
-
Second Amended and Restated Employment Agreement of CEO Nader Z. Pourhassan Ph.D
(Filed With SEC on June 19, 2020)
-
Amended and Restated Employment Agreement CFO Michael D. Mulholland
(Filed With SEC on June 19, 2020)
-
Amendment No. 5 to the 2012 Equity Incentive
(Filed With SEC on June 19, 2020)
-
Form of Stock Option Agreement for Employees
(Filed With SEC on June 19, 2020)
-
Form of Performance Stock Unit Agreement
(Filed With SEC on June 19, 2020)
-
Form of Restricted Stock Unit Agreement
(Filed With SEC on June 19, 2020)
-
Form of Performance Share Award Agreement
(Filed With SEC on April 9, 2020)
-
Secured Convertible Promissory Note, as amended
(Filed With SEC on April 6, 2020)
-
Security Agreement
(Filed With SEC on April 6, 2020)
-
Securities Purchase Agreement
(Filed With SEC on April 6, 2020)
-
Form of Series D Warrant Agreement
(Filed With SEC on February 3, 2020)
-
Form of Subscription Agreement
(Filed With SEC on February 3, 2020)
-
Form of Amendment to Executive Officer Employment Agreements
(Filed With SEC on January 9, 2020)
-
Employment Agreement by and between CytoDyn Inc. and Maura Fleming, dated January 6, 2020
(Filed With SEC on January 9, 2020)
-
Employment Agreement by and between CytoDyn Inc. and Craig S. Eastwood, dated December 6, 2019
(Filed With SEC on January 9, 2020)
-
Supply Agreement between CytoDyn Inc. and Vyera Pharmaceuticals, LLC, dated December 17, 2019
(Filed With SEC on January 9, 2020)
-
Form of Warrant Exercise Agreement
(Filed With SEC on December 27, 2019)
-
Form of Subscription Agreement
(Filed With SEC on December 27, 2019)
-
Form of Warrant Agreement
(Filed With SEC on December 27, 2019)
-
Form of Subscription Agreement
(Filed With SEC on November 7, 2019)
-
Form of Subscription Agreement
(Filed With SEC on October 22, 2019)
-
Form of Series C Warrant Agreement
(Filed With SEC on October 22, 2019)
-
Form of Subscription Agreement
(Filed With SEC on October 3, 2019)
-
Form of Subscription Agreement
(Filed With SEC on September 19, 2019)
-
Placement Agent Agreement
(Filed With SEC on August 29, 2019)
-
Form of Series C Subscription Agreement
(Filed With SEC on August 29, 2019)
-
Form of Registered Direct Subscription Agreement
(Filed With SEC on August 29, 2019)
-
Form of Registered Direct Warrant Agreement
(Filed With SEC on August 29, 2019)
-
Product Specific Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019
(Filed With SEC on August 14, 2019)
-
Master Services Agreement between CytoDyn Inc. and Samsung BioLogics Co., Ltd, dated April 1, 2019
(Filed With SEC on August 14, 2019)
-
Description of the Registrants Capital Stock
(Filed With SEC on August 14, 2019)
-
Consulting Agreement, dated July 15, 2019, between CytoDyn Inc. and David F. Welch, Ph.D
(Filed With SEC on July 19, 2019)
-
Consulting Agreement, dated July 15, 2019, between CytoDyn Inc. and Scott A. Kelly, M.D
(Filed With SEC on July 19, 2019)
-
Form of Exercise Agreement
(Filed With SEC on May 9, 2019)
-
Form of Subscription Agreement
(Filed With SEC on April 5, 2019)
-
Form of Warrant Agreement
(Filed With SEC on April 5, 2019)
-
Placement Agent Agreement
(Filed With SEC on April 5, 2019)
-
Form of Subscription Agreement
(Filed With SEC on March 20, 2019)
-
Form of Series C Warrant Agreement
(Filed With SEC on March 20, 2019)
-
Placement Agent Agreement
(Filed With SEC on January 31, 2019)
-
Form of Subscription Agreement
(Filed With SEC on January 31, 2019)
-
Convertible Promissory Note Warrant Agreement
(Filed With SEC on January 31, 2019)
-
Form of Warrant Agreement
(Filed With SEC on January 31, 2019)
-
Convertible Promissory Note
(Filed With SEC on January 30, 2019)
-
Security Agreement
(Filed With SEC on January 30, 2019)
-
Securities Purchase Agreement
(Filed With SEC on January 30, 2019)
-
Form of Warrant to Purchase Common Stock
(Filed With SEC on January 3, 2019)
-
Form of Subscription Agreement
(Filed With SEC on January 3, 2019)
-
Form of Convertible Promissory Note
(Filed With SEC on January 3, 2019)